Skip to content

Evaluating The Effect of Using An Mobile-Application on The Management of Chemotherapy Complication and Quality of Life in Breast Cancer Patients

Evaluation of the effect of using mobile application on the management of chemotherapy side effects and quality of life in patients with breast cancer

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230402057801N1
Enrollment
72
Registered
2023-05-12
Start date
2023-05-05
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer. Malignant neoplasm of breast

Interventions

Intervention 1: Intervention group: Receiving chemotherapy in the usual way, along with using the application for 4 weeks at the beginning of the study, the complications of the participating patients

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Literate patients Patients diagnosed with breast cancer Patients undergoing chemotherapy Patients with smartphones that can use this application Ability and willingness to participate in the study

Exclusion criteria

Exclusion criteria: Patients with chronic mental problems and psychiatric diseases, including major depressive disorder and anxiety disorders Presence or history of uncontrolled medical conditions other than cancer Patients participating in another study related to symptom management Patients who undergo radiotherapy and biotherapy at the same time as chemotherapy

Design outcomes

Primary

MeasureTime frame
Evaluation of complications and quality of life of the participants. Timepoint: At the beginning of the study (before the start of the intervention) and 4 weeks after. Method of measurement: using two standard questionnaires QLQ-BR23 and.

Secondary

MeasureTime frame
Evaluation of the satisfaction of the participants in the intervention group in connection with the use of the application. Timepoint: At the beginning of the study and 4 weeks after using the application. Method of measurement: Using a standard satisfaction questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoume Sarbaz DinAbadi

Mashhad University of Medical Sciences

sarbazm2006@gmail.com+98 915 519 9599

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026